Accuray Incorporated (ARAY) - Total Liabilities
Based on the latest financial reports, Accuray Incorporated (ARAY) has total liabilities worth $405.89 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Accuray Incorporated - Total Liabilities Trend (2002–2025)
This chart illustrates how Accuray Incorporated's total liabilities have evolved over time, based on quarterly financial data. See ARAY working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Accuray Incorporated Competitors by Total Liabilities
The table below lists competitors of Accuray Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bicicletas Monark S.A
SA:BMKS3
|
Brazil | R$44.86 Million |
|
Centric Holdings S.A
AT:CENTR
|
Greece | €11.16 Million |
|
Daewon Co. Ltd
KQ:007680
|
Korea | ₩219.50 Billion |
|
Midland Exploration Inc
V:MD
|
Canada | CA$2.11 Million |
|
Daebo Magnetic Co.Ltd
KQ:290670
|
Korea | ₩29.68 Billion |
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
USA | $139.57 Million |
|
V-Tac Technology Co Ltd
TWO:6229
|
Taiwan | NT$978.22 Million |
|
Arizona Lithium Ltd
AU:AZL
|
Australia | AU$2.27 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down Accuray Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ARAY market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Accuray Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Accuray Incorporated (2002–2025)
The table below shows the annual total liabilities of Accuray Incorporated from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $389.07 Million | -8.14% |
| 2024-06-30 | $423.54 Million | -0.47% |
| 2023-06-30 | $425.56 Million | +1.40% |
| 2022-06-30 | $419.66 Million | +2.04% |
| 2021-06-30 | $411.26 Million | -3.75% |
| 2020-06-30 | $427.29 Million | +10.04% |
| 2019-06-30 | $388.31 Million | +17.64% |
| 2018-06-30 | $330.10 Million | -8.29% |
| 2017-06-30 | $359.93 Million | -12.08% |
| 2016-06-30 | $409.37 Million | +3.85% |
| 2015-06-30 | $394.19 Million | -0.62% |
| 2014-06-30 | $396.64 Million | +7.46% |
| 2013-06-30 | $369.09 Million | +37.06% |
| 2012-06-30 | $269.30 Million | +24.99% |
| 2011-06-30 | $215.46 Million | +131.41% |
| 2010-06-30 | $93.11 Million | -22.72% |
| 2009-06-30 | $120.48 Million | -26.64% |
| 2008-06-30 | $164.24 Million | -20.53% |
| 2007-06-30 | $206.67 Million | -5.84% |
| 2006-06-30 | $219.48 Million | +53.45% |
| 2005-06-30 | $143.03 Million | +118.72% |
| 2003-06-30 | $65.39 Million | +83.92% |
| 2002-06-30 | $35.56 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more